EurActiv.com

EU news and policy debates across languages

25/07/2016

MEP: New clinical trial rules will boost EU pharma research

Topic: clinical trials


Health & Consumers 13-06-2016

New medical devices rules should avoid ‘unnecessary’ red tape, industry says

The implementation of new rules on medical devices should avoid extra burdens and unnecessary bureaucracy, health industry officials have told EurActiv.com.

EU project hopes to phase out animal-testing

When chemicals are considered too dangerous to be tested on humans, animals have long been the answer to some scientific quandaries. The EU project ToxRisk will act as Europe's flagship for safety assessments that do not require the use of animals. EurActiv Germany reports.
Agriculture & Food 20-11-2015

Food industry wants common science principles to boost trust

The EU's food and drinks industry has developed a set of principles for research conduct that will apply to the sector.
Health & Consumers 22-10-2014

Ben Goldacre: Pharma industry has destroyed its own reputation

EXCLUSIVE: The great tragedy for the pharmaceutical industry is that it keeps denying that it lobbies against transparency in clinical trials, says Ben Goldacre.

EU Ombudsman: Clinical trials face new transparency challenges

Medical researchers in Europe are facing new challenges over access to clinical trials data, according to the European Ombudsman Emily O'Reilly.

Cancer research at a crossroads in Germany

A new EU regulation is meant to make clinical trials easier and more transparent, a pivotal tool in the fight against deadly diseases like cancer. But researchers in Germany warn that the country may lose its role as a leader in international medicine. EurActiv Germany reports.
Health & Consumers 11-06-2014

Growing concerns over medicines agency's proposed rules for transparency

A growing number of health and consumer advocacy organisations are urging the European Medicines Agency (EMA) to rethink its proposals to restrict the viewing of clinical trial results ahead of a board meeting Thursday (12 June).
Health & Consumers 21-05-2014

EU Ombudsman worried over lack of transparency at medicines agency

The European Ombudsman, Emily O'Reilly, has written to the European Medicines Agency (EMA), expressing concern about a significant change of clinical trial data transparency policy.

EU rules ‘mean children can't get life-saving cancer drugs’

Children with cancer are being denied access to potentially life-saving medicines because European Union rules allow drug firms to waive the need to test some drugs in paediatric trials, researchers said on Monday (10 February).
Health & Consumers 20-12-2013

EU Parliament, ministers agree to more clinical trial transparency in clinical trials

MEPs reached on Friday (20 December) an agreement with member states on the clinical trials directive.
Health & Consumers 22-10-2013

Ending drug trial secrecy is a boon for R&D, says EU agency

Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug developers".
Health & Consumers 29-08-2013

Health experts critical of pharma industry's new transparency rules

The European pharmaceutical industry association EFPIA has published new ethical commitments on clinical trials aimed at allaying accusations that a lack of transparency on how new drugs are tested is hurting patients. Critics however are unconvinced.
Health & Consumers 25-07-2013

Pharma industry downplays lobbyism with patient groups

In a blog entry posted yesterday (24 July), the director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Richard Bergström, rebuffed reports that the pharmaceutical industry is trying to limit transparency as it seeks to work together with patient groups on clinical trials.
Health & Consumers 23-07-2013

Pharma industry tries to mobilise patient groups in clinical trials battle

The pharmaceutical industry is trying to 'mobilise' patient groups into lobbying against EU plans that will force companies to publish data from their clinical trials, according to an e-mail seen by a British newspaper.
Health & Consumers 30-05-2013

MEPs give resounding ‘yes’ to new clinical trial rules

A panel of European Parliament lawmakers gave unanimous backing on Wednesday (29 May) to new draft EU rules on clinical trials that could represent a huge step forward for research on new, life-saving drugs.
Health & Consumers 02-05-2013

Court orders EU medicines agency to withhold clinical trial results

The General Court of the European Union has ordered the European Medicines Agency (EMA) not to release documents on clinical trials, after two access-to-documents were requested, at least until the Court has issued a final ruling.
Health & Consumers 30-04-2013

Health NGO pushes for more transparency in clinical trials

The European Commission's proposed revision on the Clinical Trials Directive is an important step forward, but does not go far enough, says the Cochrane Collaboration, a healthcare NGO which advocates more transparency in clinical trials.
Health & Consumers 19-04-2013

Clinical trials debate shifts from research to transparency ahead of EU vote

Since the European Commission tabled its proposal to revise the Clinical Trials Directive last July, the focus in the debate has broadly shifted from supporting European research to patient safety and transparency, suggesting health campaigners have gained the upper hand over big pharmaceutical firms. The legislation will be debated in the European Parliament’s Environment Committee on 24 April.
Health & Consumers 04-04-2013

Clinical trials directive: The Parliament's political dilemna

The most contentious political questions in the Clinical Trials Directive relate to disclosure – whether, how and when the results of clinical trials should be made public and whether pharmaceutical companies can claim ownership over the data generated by them. But if anyone owns the results of clinical trials it is the volunteers who participated, writes Jim Murray.
Health & Consumers 11-03-2013

US pharma firm seeks to stop EU agency releasing drug data

The European Medicines Agency, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny, a move that is creating tensions with drugmakers worried about preserving business confidentiality.
Health & Consumers 08-03-2013

Health experts urge greater gender balance in clinical trials

Too few women are taking part in clinical tests to develop new drugs, putting their lives at risk as women's bodies react differently to medicines, health experts said ahead of International Women's Day.
Health & Consumers 08-03-2013

Medical director: Women under-represented in clinical tests

The lack of gender balance in clinical tests affects almost all medical sectors, but is particularly relevant in cardiovascular diseases where only 33% of trials participants are women. On International Women's Day, Marco Stramba-Badiale is calling for an update of the EU's Clinical Trials Directive to address this imbalance.
Health & Consumers 26-02-2013

OECD urges harmonisation of clinical trials to save lives

The OECD is urging its member governments to harmonise their clinical trial approval processes, citing a decline in the pharmaceutical sector in the EU, where the number of applications for clinical trials fell 25% between 2007 and 2011.
Health & Consumers 19-07-2012

MEP: New clinical trial rules will boost EU pharma research

The European Commission's proposed regulation on clinical trials will help the European pharma industry to stop research centres from fleeing to Asia and America, says Philippe Juvin, a French centre-right MEP.